Larimar Therapeutics Inc (NASDAQ:LRMR) currently has a daily average trading volume of 1.29M but it saw 1563593 shares traded in last market. With a market cap of 197.21M USD, the company’s current market price of $3.08 came falling about -5.23 while comparing to the previous closing price of $3.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.20 and as low as $1.61. In the recent trading on the day, stock has struck highest price mark of $2.87 while lowest mark touched by it was $3.2596.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Truist which initiated the stock as “Buy” in its note to investors issued on January 29, 2025, recommending a price target of $18 for it. Wedbush also issued its recommendations for the stock as it initiated the price target for the stock is $22.
Over the week, LRMR’s stock price is moving 12.41% up while it is 68.31% when we observe its performance for the past one month. Year-to-date it is -57.75% down and over the past year, the stock is showing a downside performance of -20.41%.
The company is expected to be releasing its next quarterly report on 2025-Apr-30, for which analysts forecasted an EPS of -0.49 while estimate for next year EPS is -1.93.
Currently, Larimar Therapeutics Inc’s total number of outstanding shares is 64.03M with 1.43% of that held by the insiders while 108.14% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -64.33% and return on equity (ROE) at -50.77%. Stock’s beta reads 0.85. Stock has a price to book (P/B) ratio of 1.37. Its return on asset (ROA) is -45.52% on average.
